{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T15:29:56Z","timestamp":1787671796141,"version":"build-2736575974"},"reference-count":40,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"24","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Am Acad Orthop Surg","JAAOS"],"published-print":{"date-parts":[[2018,12,15]]},"abstract":"<jats:p>Atypical femur fractures associated with long-term bisphosphonate use can be challenging injuries to manage. Not only do they have a prolonged healing time and increased rate of nonunion as compared to typical femur fractures, intraoperative complications are not infrequent and can be catastrophic. Given the pathologic nature of these fractures, a multidisciplinary approach to the patient's care is necessary. Treatment begins with medical optimization and careful surgical planning. Radiographic characteristics of the fracture and femoral osteology dictate reduction strategy, adjunctive surgical techniques, and implant choice. Intraoperative complications including malreduction, iatrogenic fracture, and fracture propagation can be avoided with thoughtful planning. The purpose of this article is to discuss the technical aspects of surgical management of atypical femur fractures. We also discuss management of intraoperative complications and treatment failure. Finally, we provide an update on recommendations for postoperative medical treatment and management of the contralateral femur.<\/jats:p>","DOI":"10.5435\/jaaos-d-16-00717","type":"journal-article","created":{"date-parts":[[2018,9,26]],"date-time":"2018-09-26T16:11:04Z","timestamp":1537978264000},"page":"864-871","source":"Crossref","is-referenced-by-count":26,"title":["Surgical Management of Atypical Femur Fractures Associated With Bisphosphonate Therapy"],"prefix":"10.5435","volume":"26","author":[{"given":"Michael","family":"Githens","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew R.","family":"Garner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reza","family":"Firoozabadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20230714","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1007\/s00068-007-7004-x","article-title":"Hip, osteoporosis: New paradigm","volume":"34","author":"Komadina","year":"2008","journal-title":"Eur J Trauma Emerg Surg"},{"key":"R2-20230714","first-page":"1609","article-title":"Bisphosphonates in orthopaedic surgery","volume":"87","author":"Morris","year":"2005","journal-title":"J Bone Joint Surg Am"},{"key":"R3-20230714","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/s00198-009-1034-7","article-title":"The potential impact of new National Osteoporosis Foundation guidance on treatment patterns","volume":"21","author":"Dawson-Hughes","year":"2010","journal-title":"Osteoporos Int"},{"key":"R4-20230714","first-page":"1535","article-title":"Randomised trial of effect of alendronate on risk of fracture in women with existing vertebral fractures: Fracture Intervention Trial Research Group","volume":"348","author":"Black","year":"1996"},{"key":"R5-20230714","first-page":"CD001155","article-title":"Alendronate for the primary and secondary prevention of osteoporotic fractures in postmenopausal women","author":"Wells","year":"2008","journal-title":"Cochrane Database Syst Rev"},{"key":"R6-20230714","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1056\/NEJMoa1001086","article-title":"Bisphosphonates and fractures of the subtrochanteric or diaphyseal femur","volume":"362","author":"Black","year":"2010","journal-title":"N Engl J Med"},{"key":"R7-20230714","doi-asserted-by":"crossref","first-page":"e20","DOI":"10.5435\/JAAOS-D-15-00488","article-title":"Atypical femur fractures associated with diphosphonate use","volume":"24","author":"Shen","year":"2016","journal-title":"J Am Acad Orthop Surg"},{"key":"R8-20230714","doi-asserted-by":"crossref","first-page":"297","DOI":"10.2106\/JBJS.K.01181","article-title":"Bisphosphonates and nonhealing femoral fractures: Analysis of the FDA Adverse Event Reporting System (FAERS) and international safety efforts: A systematic review from the Research on Adverse Drug Events and Reports (RADAR) project","volume":"95","author":"Edwards","year":"2013","journal-title":"J Bone Joint Surg Am"},{"key":"R9-20230714","doi-asserted-by":"crossref","first-page":"2267","DOI":"10.1002\/jbmr.253","article-title":"Atypical subtrochanteric and diaphyseal femoral fractures: Report of a task force of the American Society for Bone and Mineral Research","volume":"25","author":"Shane","year":"2010","journal-title":"J Bone Miner Res"},{"key":"R10-20230714","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1002\/jbmr.2748","article-title":"Incidence and characteristics of atypical femoral fractures: Clinical and geometrical data","volume":"31","author":"Mahjoub","year":"2016","journal-title":"J Bone Miner Res"},{"key":"R11-20230714","doi-asserted-by":"crossref","first-page":"5258","DOI":"10.1210\/jc.2010-1571","article-title":"Cumulative alendronate dose and the long-term absolute risk of subtrochanteric and diaphyseal femur fractures: A register-based national cohort analysis","volume":"95","author":"Abrahamsen","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"key":"R12-20230714","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/jbmr.1998","article-title":"Atypical subtrochanteric and diaphyseal femoral fractures: Second report of a task force of the American Society for Bone and Mineral Research","volume":"29","author":"Shane","year":"2014","journal-title":"J Bone Miner Res"},{"key":"R13-20230714","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.bone.2013.03.018","article-title":"Atypical incomplete femoral fractures in asymptomatic patients on long term bisphosphonate therapy","volume":"55","author":"Allison","year":"2013","journal-title":"Bone"},{"key":"R14-20230714","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.2214\/AJR.11.7442","article-title":"Frequency of incomplete atypical femoral fractures in asymptomatic patients on long-term bisphosphonate therapy","volume":"198","author":"La Rocca Vieira","year":"2012","journal-title":"AJR Am J Roentgenol"},{"key":"R15-20230714","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1007\/s11999-013-3352-5","article-title":"Are race and sex associated with the occurrence of atypical femoral fractures?","volume":"472","author":"Marcano","year":"2014","journal-title":"Clin Orthop Relat Res"},{"key":"R16-20230714","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.bone.2012.02.632","article-title":"Clinical correlates of atypical femoral fracture","volume":"51","author":"Lo","year":"2012","journal-title":"Bone"},{"key":"R17-20230714","doi-asserted-by":"crossref","first-page":"456","DOI":"10.4158\/EP12179.OR","article-title":"A retrospective review of patients with atypical femoral fractures while on long-term bisphosphonates: Including pertinent biochemical and imaging studies","volume":"19","author":"Markman","year":"2013","journal-title":"Endocr Pract"},{"key":"R18-20230714","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1016\/j.bone.2010.12.033","article-title":"Atypical fractures and bisphosphonate therapy: A cohort study of patients with femoral fracture with radiographic adjudication of fracture site and features","volume":"48","author":"Giusti","year":"2011","journal-title":"Bone"},{"key":"R19-20230714","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1002\/jbmr.233","article-title":"Trends in incidence of subtrochanteric fragility fractures and bisphosphonate use among the US elderly, 1996-2007","volume":"26","author":"Wang","year":"2011","journal-title":"J Bone Miner Res"},{"key":"R20-20230714","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1097\/BOT.0000000000000516","article-title":"Healing time and complications in operatively treated atypical femur fractures associated with bisphosphonate use: A Multicenter Retrospective Cohort","volume":"30","author":"Bogdan","year":"2016","journal-title":"J Orthop Trauma"},{"key":"R21-20230714","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.bone.2010.05.019","article-title":"Atypical fractures of the femur and bisphosphonate therapy: A systematic review of case\/case series studies","volume":"47","author":"Giusti","year":"2010","journal-title":"Bone"},{"key":"R22-20230714","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1097\/BOT.0000000000000539","article-title":"A review of atypical femoral fractures from a tertiary care teaching hospital: An alarming trend?","volume":"30","author":"Black","year":"2016","journal-title":"J Orthop Trauma"},{"key":"R23-20230714","doi-asserted-by":"crossref","first-page":"3813","DOI":"10.1016\/j.ejrad.2011.04.003","article-title":"Role of MRI in hip fractures, including stress fractures, occult fractures, avulsion fractures","volume":"81","author":"Nachtrab","year":"2012","journal-title":"Eur J Radiol"},{"key":"R24-20230714","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1097\/BOT.0b013e31827240ae","article-title":"Surgical treatment improves clinical and functional outcomes for patients who sustain incomplete bisphosphonate-related femur fractures","volume":"27","author":"Egol","year":"2013","journal-title":"J Orthop Trauma"},{"key":"R25-20230714","doi-asserted-by":"crossref","first-page":"2028","DOI":"10.1007\/s11999-011-1828-8","article-title":"Nonoperative versus prophylactic treatment of bisphosphonate-associated femoral stress fractures","volume":"469","author":"Banffy","year":"2011","journal-title":"Clin Orthop Relat Res"},{"key":"R26-20230714","doi-asserted-by":"crossref","first-page":"2295","DOI":"10.1007\/s11999-012-2412-6","article-title":"Bisphosphonate-associated femur fractures have high complication rates with operative fixation","volume":"470","author":"Prasarn","year":"2012","journal-title":"Clin Orthop Relat Res"},{"key":"R27-20230714","doi-asserted-by":"crossref","first-page":"e5","DOI":"10.2106\/JBJS.CC.N.00235","article-title":"Treating atypical femoral fractures related to bisphosphonates","volume":"5","author":"Marc","year":"2015","journal-title":"JBJS Case Connect"},{"key":"R28-20230714","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1359\/jbmr.040117","article-title":"Differential effects of teriparatide on BMD after treatment with raloxifene or alendronate","volume":"19","author":"Ettinger","year":"2004","journal-title":"J Bone Miner Res"},{"key":"R29-20230714","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1097\/SPC.0b013e3283552d7d","article-title":"Atypical femoral fractures: Epidemiology, etiology, and patient management","volume":"6","author":"Donnelly","year":"2012","journal-title":"Curr Opin Support Palliat Care"},{"key":"R30-20230714","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1210\/jc.2010-2520","article-title":"Teriparatide, vitamin D, and calcium healed bilateral subtrochanteric stress fractures in a postmenopausal woman with a 13-year history of continuous alendronate therapy","volume":"96","author":"Gomberg","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"key":"R31-20230714","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1056\/NEJMc1107029","article-title":"Atypical femoral fractures and bone turnover","volume":"365","author":"Jamal","year":"2011","journal-title":"N Engl J Med"},{"key":"R32-20230714","doi-asserted-by":"crossref","first-page":"3656","DOI":"10.1210\/endo.142.8.8300","article-title":"Bone morphogenetic protein 2 stimulates osteoclast differentiation and survival supported by receptor activator of nuclear factor-\u03baB ligand","volume":"142","author":"Itoh","year":"2001","journal-title":"Endocrinology"},{"key":"R33-20230714","first-page":"809","article-title":"BMP and osteoclastogenesis [Japan]","volume":"16","author":"Nakamura","year":"2006","journal-title":"Clin Calcium"},{"key":"R34-20230714","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1359\/jbmr.060411","article-title":"Bone morphogenetic proteins in bone stimulate osteoclasts and osteoblasts during bone development","volume":"21","author":"Okamoto","year":"2006","journal-title":"J Bone Miner Res"},{"key":"R35-20230714","first-page":"186","article-title":"The outcome of surgically treated femur fractures associated with long-term bisphosphonate use","volume":"71","author":"Weil","year":"2011","journal-title":"J Trauma"},{"key":"R36-20230714","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1302\/0301-620X.96B5.32887","article-title":"Post-operative outcomes of atypical femoral subtrochanteric fracture in patients on bisphosphonate therapy","volume":"96-B","author":"Teo","year":"2014","journal-title":"Bone Joint J"},{"key":"R37-20230714","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1007\/s13244-014-0371-z","article-title":"Stress fracture of the pelvis and lower limbs including atypical femoral fractures: A review","volume":"6","author":"Tins","year":"2015","journal-title":"Insights Imaging"},{"key":"R38-20230714","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1177\/230949901101900121","article-title":"Alendronate-associated femoral insufficiency fractures and femoral stress reactions","volume":"19","author":"Wang","year":"2011","journal-title":"J Orthop Surg (Hong Kong)"},{"key":"R39-20230714","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1007\/s00256-016-2346-2","article-title":"Long-term radiographic follow-up of bisphosphonate-associated atypical femur fractures","volume":"45","author":"Favinger","year":"2016","journal-title":"Skeletal Radiol"},{"key":"R40-20230714","doi-asserted-by":"crossref","first-page":"2468","DOI":"10.1016\/j.injury.2015.09.031","article-title":"High revision rate but good healing capacity of atypical femoral fractures: A comparison with common shaft fractures","volume":"46","author":"Schilcher","year":"2015","journal-title":"Injury"}],"container-title":["Journal of the American Academy of Orthopaedic Surgeons"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00124635-201812150-00002","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T14:49:28Z","timestamp":1787669368000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00124635-201812150-00002"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,12,15]]},"references-count":40,"journal-issue":{"issue":"24","published-print":{"date-parts":[[2018]]}},"URL":"https:\/\/doi.org\/10.5435\/jaaos-d-16-00717","relation":{},"ISSN":["1067-151X","1940-5480"],"issn-type":[{"value":"1067-151X","type":"print"},{"value":"1940-5480","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,12,15]]}}}